| Code | Description | Claims | Beneficiaries | Total Paid |
| 96361 |
Intravenous infusion, hydration; each additional hour |
11,547 |
9,939 |
$2.24M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
17,717 |
16,624 |
$2.20M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
19,026 |
18,084 |
$2.16M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
14,629 |
13,562 |
$2.11M |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
4,732 |
4,546 |
$1.24M |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
5,649 |
5,439 |
$515K |
| 70450 |
Computed tomography, head or brain; without contrast material |
3,521 |
3,340 |
$473K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
1,995 |
1,923 |
$472K |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
4,051 |
1,732 |
$398K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
4,296 |
3,797 |
$283K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
2,641 |
2,535 |
$276K |
| 80053 |
Comprehensive metabolic panel |
29,798 |
26,119 |
$221K |
| G0378 |
Hospital observation service, per hour |
1,495 |
1,061 |
$217K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
13,254 |
11,905 |
$217K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
1,590 |
1,138 |
$198K |
| 99291 |
Critical care, evaluation and management of the critically ill patient, first 30-74 minutes |
941 |
888 |
$170K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
895 |
876 |
$164K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
5,971 |
5,585 |
$164K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
2,119 |
2,013 |
$163K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
839 |
812 |
$162K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
11,289 |
9,341 |
$152K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
1,944 |
1,891 |
$133K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
30,040 |
26,082 |
$129K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
10,850 |
9,554 |
$108K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
8,207 |
6,976 |
$104K |
| 76830 |
Ultrasound, transvaginal |
1,466 |
1,429 |
$103K |
| C1713 |
Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) |
268 |
264 |
$90K |
| 36415 |
Collection of venous blood by venipuncture |
36,842 |
30,728 |
$87K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
2,310 |
1,802 |
$83K |
| 84484 |
|
8,107 |
6,192 |
$78K |
| 71046 |
Radiologic examination, chest; 2 views |
2,790 |
2,700 |
$78K |
| 71045 |
Radiologic examination, chest; single view |
6,181 |
5,692 |
$73K |
| 76801 |
|
1,160 |
1,059 |
$71K |
| 96376 |
|
5,045 |
3,680 |
$70K |
| 93971 |
|
768 |
747 |
$65K |
| U0004 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r |
1,377 |
1,325 |
$61K |
| 84443 |
Thyroid stimulating hormone (TSH) |
5,924 |
5,686 |
$57K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
695 |
682 |
$54K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
6,089 |
5,058 |
$50K |
| 83690 |
|
9,996 |
9,043 |
$44K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
15,212 |
12,683 |
$43K |
| 84145 |
|
1,926 |
1,745 |
$41K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
291 |
285 |
$40K |
| 83880 |
|
3,101 |
2,866 |
$40K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
1,056 |
1,048 |
$39K |
| 87040 |
|
3,299 |
1,898 |
$38K |
| 83605 |
|
4,467 |
3,880 |
$37K |
| 85379 |
|
2,885 |
2,766 |
$35K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
1,009 |
993 |
$33K |
| 73630 |
|
1,400 |
1,338 |
$33K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
1,668 |
1,354 |
$33K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
1,760 |
1,636 |
$33K |
| 81001 |
|
11,968 |
11,002 |
$31K |
| 0202U |
Oncology (prostate), multianalyte, gene expression profiling |
6,001 |
5,714 |
$30K |
| 72100 |
|
877 |
857 |
$27K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
4,710 |
4,461 |
$27K |
| 73610 |
|
1,121 |
1,068 |
$26K |
| 81025 |
|
6,367 |
6,051 |
$25K |
| 73030 |
|
982 |
929 |
$25K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
1,213 |
483 |
$24K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
1,280 |
649 |
$22K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
892 |
885 |
$22K |
| 83735 |
|
7,189 |
6,400 |
$22K |
| 87077 |
|
3,906 |
3,462 |
$21K |
| 73130 |
|
771 |
743 |
$21K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
2,060 |
2,007 |
$21K |
| 90715 |
|
1,018 |
992 |
$20K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
1,185 |
1,136 |
$19K |
| 87181 |
|
3,511 |
3,111 |
$19K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
2,663 |
2,265 |
$17K |
| 74018 |
|
824 |
784 |
$17K |
| 12001 |
|
112 |
111 |
$16K |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
4,321 |
3,784 |
$16K |
| 84439 |
|
1,565 |
1,514 |
$15K |
| 80061 |
Lipid panel |
1,794 |
1,768 |
$15K |
| 85027 |
|
3,786 |
3,492 |
$15K |
| 84702 |
|
1,978 |
1,720 |
$15K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
1,103 |
1,072 |
$15K |
| 10060 |
|
95 |
92 |
$15K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
313 |
286 |
$15K |
| J1170 |
Injection, hydromorphone, up to 4 mg |
6,032 |
3,642 |
$14K |
| 87070 |
|
2,284 |
2,008 |
$14K |
| 71250 |
|
174 |
171 |
$14K |
| 73562 |
|
621 |
597 |
$13K |
| 93970 |
|
140 |
134 |
$13K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
310 |
294 |
$12K |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
4,649 |
2,737 |
$12K |
| 82962 |
|
5,285 |
3,367 |
$11K |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
111 |
110 |
$11K |
| 87081 |
|
1,276 |
1,255 |
$11K |
| 81000 |
|
2,882 |
2,641 |
$10K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
1,075 |
1,047 |
$10K |
| 85610 |
|
4,694 |
4,161 |
$10K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
155 |
147 |
$10K |
| 36000 |
|
1,841 |
1,782 |
$10K |
| 73110 |
|
442 |
410 |
$9K |
| 86140 |
|
1,560 |
1,421 |
$9K |
| 87075 |
|
1,531 |
1,340 |
$9K |
| 86900 |
|
1,901 |
1,698 |
$9K |
| 87581 |
|
155 |
147 |
$9K |
| J2704 |
Injection, propofol, 10 mg |
3,418 |
3,015 |
$8K |
| 86850 |
|
1,422 |
1,358 |
$8K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
2,378 |
2,012 |
$8K |
| 76642 |
|
153 |
136 |
$7K |
| 87205 |
|
2,305 |
2,046 |
$7K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
779 |
761 |
$7K |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
3,944 |
2,791 |
$7K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
1,169 |
1,120 |
$6K |
| 70496 |
|
27 |
27 |
$6K |
| 81003 |
|
3,608 |
3,450 |
$6K |
| 86901 |
|
1,911 |
1,706 |
$6K |
| J7050 |
Infusion, normal saline solution, 250 cc |
2,968 |
1,957 |
$6K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
10,442 |
9,305 |
$6K |
| 84703 |
|
1,290 |
1,246 |
$6K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
1,061 |
1,027 |
$5K |
| 85732 |
|
1,523 |
1,429 |
$5K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
173 |
163 |
$5K |
| J2060 |
Injection, lorazepam, 2 mg |
2,522 |
1,831 |
$5K |
| 94060 |
|
103 |
100 |
$5K |
| J0131 |
Injection, acetaminophen, not otherwise specified,10 mg |
450 |
413 |
$5K |
| 11045 |
|
49 |
25 |
$4K |
| 73564 |
|
120 |
119 |
$4K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
12,360 |
9,610 |
$4K |
| 82150 |
|
1,140 |
1,095 |
$4K |
| 82550 |
|
1,187 |
980 |
$4K |
| 86803 |
|
420 |
409 |
$4K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
1,683 |
1,656 |
$4K |
| 82553 |
|
365 |
298 |
$4K |
| 82077 |
|
2,300 |
2,098 |
$4K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
51 |
51 |
$4K |
| 85007 |
|
1,270 |
1,172 |
$4K |
| 86592 |
|
622 |
605 |
$3K |
| 87486 |
|
155 |
147 |
$3K |
| C2627 |
Catheter, suprapubic/cystoscopic |
297 |
284 |
$3K |
| 70498 |
|
26 |
26 |
$3K |
| 87088 |
|
643 |
619 |
$3K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
2,959 |
2,824 |
$3K |
| A9579 |
Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml |
307 |
290 |
$3K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
224 |
213 |
$3K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
105 |
99 |
$3K |
| 87507 |
|
55 |
53 |
$3K |
| 70486 |
|
36 |
36 |
$2K |
| 94729 |
|
103 |
100 |
$2K |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
1,083 |
955 |
$2K |
| J3490 |
Unclassified drugs |
1,182 |
904 |
$2K |
| 93975 |
|
31 |
29 |
$2K |
| J0690 |
Injection, cefazolin sodium, 500 mg |
933 |
846 |
$2K |
| G0279 |
Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) |
219 |
198 |
$2K |
| 94726 |
|
75 |
73 |
$2K |
| 12002 |
|
12 |
12 |
$2K |
| 85651 |
|
587 |
551 |
$2K |
| 82728 |
|
126 |
125 |
$2K |
| 85652 |
|
754 |
716 |
$2K |
| 72040 |
|
59 |
56 |
$2K |
| 73502 |
|
77 |
76 |
$1K |
| 59025 |
Fetal non-stress test |
18 |
12 |
$1K |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
86 |
85 |
$1K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
92 |
40 |
$1K |
| 87340 |
|
216 |
211 |
$1K |
| 88175 |
Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer |
102 |
101 |
$1K |
| 83550 |
|
131 |
128 |
$1K |
| 87184 |
|
298 |
284 |
$1K |
| 80143 |
|
415 |
384 |
$1K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
148 |
148 |
$1K |
| 94799 |
|
339 |
290 |
$1K |
| 85018 |
|
586 |
499 |
$1K |
| M0243 |
Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring |
12 |
12 |
$1K |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
343 |
301 |
$925.99 |
| 87807 |
|
117 |
114 |
$893.63 |
| 81002 |
|
420 |
401 |
$891.32 |
| 76870 |
|
13 |
12 |
$885.86 |
| 76816 |
Ultrasound, pregnant uterus, real time with image documentation, follow-up |
14 |
14 |
$868.83 |
| 83540 |
|
134 |
131 |
$864.47 |
| 76536 |
|
13 |
12 |
$797.90 |
| 80179 |
|
385 |
361 |
$787.77 |
| 87210 |
|
193 |
190 |
$781.49 |
| J3360 |
Injection, diazepam, up to 5 mg |
107 |
65 |
$758.28 |
| 86787 |
|
80 |
72 |
$742.30 |
| 82075 |
|
180 |
145 |
$706.44 |
| 92587 |
|
12 |
12 |
$687.79 |
| 76942 |
|
12 |
12 |
$676.72 |
| J2795 |
Injection, ropivacaine hydrochloride, 1 mg |
621 |
558 |
$668.36 |
| 96367 |
|
61 |
50 |
$668.31 |
| 71271 |
|
17 |
16 |
$636.47 |
| 87147 |
|
116 |
111 |
$605.54 |
| J0330 |
Injection, succinylcholine chloride, up to 20 mg |
98 |
88 |
$590.63 |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
1,010 |
972 |
$500.04 |
| 73140 |
|
36 |
36 |
$490.30 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
977 |
826 |
$474.28 |
| 77065 |
Tomosynthesis, mammo |
12 |
12 |
$438.25 |
| 88304 |
|
46 |
42 |
$430.19 |
| 77066 |
Tomosynthesis, mammo |
14 |
13 |
$427.74 |
| 73590 |
|
27 |
26 |
$382.65 |
| J2550 |
Injection, promethazine hcl, up to 50 mg |
1,584 |
1,209 |
$373.37 |
| 82805 |
|
75 |
65 |
$362.93 |
| 86762 |
|
57 |
56 |
$357.77 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
1,387 |
1,204 |
$356.43 |
| 85014 |
|
83 |
73 |
$339.37 |
| 82375 |
|
92 |
78 |
$330.40 |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
120 |
116 |
$298.96 |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
103 |
91 |
$275.82 |
| G0472 |
Hepatitis c antibody screening, for individual at high risk and other covered indication(s) |
137 |
132 |
$240.76 |
| 73080 |
|
14 |
14 |
$239.64 |
| 82570 |
|
55 |
50 |
$201.57 |
| J1171 |
Injection, hydromorphone, 0.1 mg |
105 |
68 |
$194.12 |
| J0780 |
Injection, prochlorperazine, up to 10 mg |
120 |
110 |
$173.85 |
| 84100 |
|
42 |
40 |
$138.08 |
| J3370 |
Injection, vancomycin hcl, 500 mg |
36 |
24 |
$130.09 |
| Q0162 |
Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
2,010 |
1,896 |
$127.27 |
| 82607 |
|
12 |
12 |
$116.64 |
| J0134 |
Injection, acetaminophen (fresenius kabi), not therapeutically equivalent to j0131, 10 mg |
30 |
30 |
$114.24 |
| 83615 |
|
68 |
54 |
$106.43 |
| J0665 |
Injection, bupivicaine, not otherwise specified, 0.5 mg |
64 |
56 |
$104.94 |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
869 |
763 |
$79.55 |
| 84436 |
|
17 |
13 |
$64.96 |
| 83050 |
|
36 |
28 |
$62.46 |
| 81015 |
|
26 |
26 |
$55.02 |
| S0119 |
Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code) |
789 |
769 |
$52.60 |
| J1644 |
Injection, heparin sodium, per 1000 units |
199 |
70 |
$49.23 |
| J2175 |
Injection, meperidine hydrochloride, per 100 mg |
26 |
17 |
$49.00 |
| J1815 |
Injection, insulin, per 5 units |
95 |
38 |
$38.66 |
| J2371 |
Injection, phenylephrine hydrochloride, 20 micrograms |
14 |
12 |
$30.04 |
| J2710 |
Injection, neostigmine methylsulfate, up to 0.5 mg |
12 |
12 |
$25.64 |
| J2919 |
Injection, methylprednisolone sodium succinate, 5 mg |
14 |
12 |
$21.44 |
| J2370 |
Injection, phenylephrine hcl, up to 1 ml |
28 |
26 |
$20.67 |
| Q0144 |
Azithromycin dihydrate, oral, capsules/powder, 1 gram |
55 |
52 |
$20.29 |
| J1790 |
Injection, droperidol, up to 5 mg |
15 |
13 |
$20.05 |
| J8540 |
Dexamethasone, oral, 0.25 mg |
152 |
111 |
$15.18 |
| J1630 |
Injection, haloperidol, up to 5 mg |
32 |
24 |
$14.38 |
| 0353U |
|
165 |
163 |
$4.31 |
| Q0244 |
Injection, casirivimab and imdevimab, 1200 mg |
20 |
12 |
$0.02 |
| G1004 |
Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program |
977 |
859 |
$0.00 |
| A9270 |
Non-covered item or service |
1,047 |
708 |
$0.00 |
| 0352U |
|
26 |
26 |
$0.00 |
| G0433 |
Infectious agent antibody detection by enzyme-linked immunosorbent assay (elisa) technique, hiv-1 and/or hiv-2, screening |
53 |
53 |
$0.00 |